Author(s):
Rutuja Sawant, Shreya Parkar, Prajackta Kegade, Akshay Gade
Email(s):
rutu0712@gmail.com
DOI:
10.5958/2231-5659.2020.00051.X 
Address:
Miss. Rutuja Sawant*, Miss. Shreya Parkar, Miss. Prajackta Kegade, Mr. Akshay Gade
Department of Pharmaceutics, M Pharmacy, University of Mumbai, Vidya Nagari, Kalina, Santacruz East, Mumbai, Maharashtra 400098.
*Corresponding Author
Published In:
Volume - 10,
Issue - 4,
Year - 2020
ABSTRACT:
Both local and systemic delivery of drugs can take place in colon. There are day by day new developments in field of colon specific drug delivery system. Colonic drug delivery has gained importance for the delivery of the drugs for the treatment of local diseases associated with the colon like Crohn’s disease, ulcerative colitis, etc. It has also used for the systemic delivery of proteins, therapeutic peptides, anti-asthmatic drugs, antihypertensive drugs and anti-diabetic agents drugs. Thereby reducing the systemic side effects treatment can be made effective if the drugs can be targeted directly into the colon. A drug need to be protected from degradation to achieve successful colon targeted drug delivery, release and absorption in upper portion of the GI tract and then to be ensured controlled release in the proximal colon. pH-dependent systems, time-dependent systems, and microbial triggered systems are the usual methods for delivering the drug to the last part of Gastro Intestinal tract. Pressure controlled colonic delivery capsules, CODESTM, and the osmotic controlled drug delivery are the newer technologies namely which are having in vivo site specificity, and feasibility of manufacturing process. The merits and demerits, novel approaches in the colon targeted drug delivery, clinical evaluation techniques and some information on the marketed dosage forms are one focused on in this review. To overcome pervious method’s limitations new systems and technologies have been developed for colon targeting. Colon targeting still need more innovative work even tough it holds a great potential and there are new developments in field of colon specific drug delivery system day by day.
Cite this article:
Rutuja Sawant, Shreya Parkar, Prajackta Kegade, Akshay Gade. Colon Targeted Drug Delivery: A Review on Novel Approaches. Asian J. Res. Pharm. Sci. 2020; 10(4):293-298. doi: 10.5958/2231-5659.2020.00051.X
Cite(Electronic):
Rutuja Sawant, Shreya Parkar, Prajackta Kegade, Akshay Gade. Colon Targeted Drug Delivery: A Review on Novel Approaches. Asian J. Res. Pharm. Sci. 2020; 10(4):293-298. doi: 10.5958/2231-5659.2020.00051.X Available on: https://ajpsonline.com/AbstractView.aspx?PID=2020-10-4-9
REFERENCE:
1. Barbara L., Teresa C., Federica B., Isabella O., Vittorio Z. / Eur. J. Pharm. Biopharm. V. 55 2003; P. 199 – 202.
2. Lachman L., Lieberman H. A., Kanig J. L. The theory and practice of industrial pharmacy / Varghese publ. house: Hind Rajasthan building, 1991; . P. 293.
3. BajpaiS.K, BajpaiM, DengreeR.chemically treated gelatin capsules for colon targeted drug delivery; A novel approach, J. Appl.Polym. Sci.,89,2003;2277-2282.
4. Watts P, Illum L. Colonic drug delivery. Drug Dev. Ind. Pharm.23: 1997; 893-913.
5. Basit A, Bloor J. Prespectives on colonic drug delivery, Business briefing. Pharmtech 2003; 185-190.
6. Watts P, Illum L. Colonic drug delivery. Drug Dev Ind Pharm23: 1997; 893- 913.
7. Van-den G. M., Kinget R. / Drug Delivery, V.2, 1995; P. 81 – 93.
8. Rama Prasad Y., Krishnaiah Y., Satyanarayana S. / J. Controlled Release, V. 51 1998; P. 281 – 287.
9. Chien YW. Oral drug delivery and delivery systems. In: Chien YW, editor. Novel drug delivery systems. New York: Marcel Dekker Inc; 1992; 139-196.
10. Antonin KH, Rak R, Beick PR, Schenker U, Hastewell J, Fox R, “The absorption of human calcitonin from the transverse colon of man” Int J Pharm. 1996;130: 33-39.
11. Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki T, Yamamoto A, Muranishi S, “Chitosan capsules for colon specific drug delivery” Improvement of insulin absorption from the rat colon. J Pharm Sci 1997; 86(9);1016-1021.
12. Jain N. K. / Advances in Controlled and novel Drug Delivery // Cbs publisher and distributors, 2008. P. 86 – 90.
13. Halsas M., Penttinen T., Veski P., Jurjenson H., Marvola M. / Pharmazie, V. 56. 2001. P. 718 – 723.
14. Kinget R., Kalala W., Vervoort L., van denMooter G. / J. Drug. Targeting, V. 6. 1998 P. 129 – 149.
15. Vinaykumar K.V, Sivakumar T, Tamizhmani T. Colon targeted drug delivery system: A review on recent approaches, Int J Pharm Biomed Sci,2011;2(1): 11-19.
16. TarakJayraj Mehta et al., Need of colon specific drug delivery system: Review on primary and novel approaches, Int J Pharm Research Dev 2011;3(1): 134-153.
17. Koteshwara K.B, Naha Anup, Nampoothiri M. Colon targeted drug delivery system: A review, Int J Research in Ayur Pharm,2011,2(1) 60-65.
18. TJ Mehta, AD Patel, Dr. MR Patel, Dr. NM Patel, Need of colon specific drug delivery system: review on primary and novel approaches. IJPRD. 2011;3: 134-157.
19. J Aurara, N Talwar, V Pathak. Colonic drug delivery challenges and opportunities- an overview. Eu Gastro Rev. 2006; 10-11.
20. 16. Stirrup V., Ledingham S. J., Thomas M., Pye G., Evans D. F. / Gut, V. 31.1990, P. 1355 – 1357.
21. BajpaiS.K, BajpaiM, DengreeR.chemically treated gelatin capsules for colon targeted drug delivery; A novel approach, J. Appl.Polym. Sci.,89, 2003, 2277-2282.
22. SarasijaS, Hota A. Colon specific drug delivery systems. Indian journal of pharmaceutical sciences,2000;62(1):1-8.
23. CHOURASIA M.K.; JAIN S.K., 2003. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm Sci. 6 (1): 33-66
24. THREVEEN C, VINAY V., KRISHNA V.A; 2011, Colon specific drug delivery systems: a review on primary and novel approaches, IJPSRR, article-031
25. KARANJIT KAUR, KWONHO KIM; 2009 Studies of chitosan/organic acid/Eudragit® RS/RL-coated system for colonic delivery International Journal of Pharmaceutics 366, 140–148.
26. VyasSP, KharRK.Gastro retentive systems. In: VyasSP, KharRK, editors. Controlled drug delivery: concepts and advances. New Delhi, VallabhPrakashan,2005;218-253.
27. Vinaykumar K.V, Sivakumar T, Tamizhmani T. Colon targeted drug delivery system: A review on recent approaches, Int J Pharm Biomed Sci ,2011;2(1): 11-19.
28. CHOURASIA M.K.; JAIN S.K., 2003. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm Sci. 6 (1): 33-66
29. THREVEEN C, VINAY V., KRISHNA V.A; 2011, Colon specific drug delivery systems: a review on primary and novel approaches, IJPSRR, article-03.
30. Edwards C. A./Anatomical and physiological basis. In physiological factors influencing drug absorption. Colonic drug absorption and metabolism // Marcel Dekker, Inc., 1993. P. 1 – 28.
31. VyasSP, KharRK.Gastro retentive systems. In: VyasSP, KharRK, editors. Controlled drug delivery: concepts and advances. New Delhi, VallabhPrakashan,2005;218-253.
32. Vinaykumar K.V, Sivakumar T, Tamizhmani T. Colon targeted drug delivery system: A review on recent approaches, Int J Pharm Biomed Sci 2011; 2(1):11-19.
33. 33.Patel G N, Patel G C, Patel R B, Oralcolon-specific drug delivery: Anoverview, Drug Delivery Technology 6:7,2006; : 62-71.
34. Taber’s cyclopedic medical dictionary / F A davis company: Philadelphia, 2001. P. 1779.
35. SD Bhalersao, PR Mahaparale. Different approaches for colon drug delivery systems: a review. IJRRPAS. 2012; 2: 529-549.
36. M Sharma, B Joshi, M Bansal, M Goswami. Colon specific delivery system: the local targeting. IRJP. 2011;2: 103-107.
37. MK Chourasia, NK Jain. Pharmaceutical approaches to colon targeted drug delivery system. J Pharm Pharma Sci.6: 2003; 33-66.
38. Scheline R. P. / J. Pharm. Sci. V. 57. 1968, P. 2021 – 2037.
39. Brondsted H., Kopecek J. / Biomaterials, V. 12.1991, P. 584 – 592.
40. Cole E, Scott R, Connor A, Wilding I, Petereit HU, Steinke C, Beckert T and Cade D. “Enteric Coated HPMC Capsules Designed to Achieve Intestinal Targeting” International Journal of Pharmaceutics 231: 2002, 83-95.
41. Scheline R. P. / J. Pharm. Sci. V. 57.1968, P. 2021 – 2037.
42. Davis SS, Hardy JG and Fara JW. Transit of Pharmaceutical dosage forms through the small intestine. Gut.1986; 886-892.
43. Chien YW. Oral drug delivery and delivery systems. In: Chien YW, editor. Novel drug delivery systems. New York: Marcel Dekker Inc. 1992; 139-196
44. KV Vinaykumar, T Sivakumar, T Tamizh mani. Colon targeting drug delivery system: a review on recent approaches. Int J Pharm Biomed Sci. 2011;2: 11-19.
45. Cole E, Scott R, Connor A, Wilding I, Petereit HU, Steinke C, Beckert T and Cade D. Enteric Coated HPMC Capsules Designed to Achieve Intestinal Targeting. International Journal of Pharmaceutics. 2002; 231:83-95.
46. Theeuwes F, Guittared G, Wong P. Delivery of drugs to colon by oral dosage forms. U. S. Patent, 4904474
47. Swanson D, Barclay B, Wong P, Theeuwes F. Nifedipine gastrointestinal therapeutics system. Am J Med 1987;8(6):3 .10.1016/0002-9343(87)90629-2.
48. Philip AK, Pathak K. Osmotic flow through asymmetric membrane: A means for controlled delivery of drugs with varying solubility. AAPS PharmSciTech7(3): 2006;1-11.
49. Philip AK, Pathak K. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug. PDA J Pharm Sci Tech 2007; 61(1):24-36.54.
50. Philip AK, Pathak K, Shakya P. Asymmetric membrane in membrane capsules: A means for achieving delayed and osmotic flow of cefadroxil. Eur J Pharm Biopharm 2008; 69(2):658-666.
51. Philip AK, Pathak K. Wet process induced phase transited drug delivery system: A means for achieving osmotic, controlled, and level an ivivc for poorly water soluble drug. Drug Dev Ind Pharm 34(7):2008;735-743.
52. Patel A, Patel D, Solanki T, Bharadia PD, Pandya VM and Modi DA. Novel approaches for colon targeted drug delivery system. Journal of Pharmaceutics and Cosmetology. 2011;1(5): 86-97.
53. Masataka K, Watanabe S, Takemura S, Sako K, Sawada T, Masuda Y, Nakamura K, Fukui M, Connor AL, Wilding IR. Scintigraphic evaluation of a novel colon-targeted delivery system (CODESTM) in healthy volunteers. J Pharm Sci 2004; 93(5):1287-1299. 74. Yang L, James S, Joseph A. Colon specific drug delivery new approaches and in vitro/ in vivo evaluation. Int J Pharm 2002; 235:1 -15.
54. Yang L, James S, Joseph A. Colon specific drug delivery new approaches and in vitro/ in vivo evaluation. Int J Pharm235: 2002;1 -15.
55. Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 2002. Mar;235(1-2):1-15 10.1016/S0378-5173(02)00004-2
56. VyasSP, KharRK.Gastro retentive systems. In: VyasSP, KharRK, editors. Controlled drug delivery: concepts and advances. New Delhi, VallabhPrakashan,2005; 218-253.
57. Sangalli ME et al., In vitro and invivo evaluation of an oral system for time and /or site specific drug delivery, J Controlled release 73;2001, 103-110.
58. Sinha VR, Kumria R. Microbially triggered drug delivery to the colon, EJPS 2003;18(1): 3-18.
59. Cole ET, Scott RA, Connor AL, Wilding IR, Petereit HU, Schminke C, et al. Enteric coated HPMC capsules designed to achieve intestinal targeting. Int J Pharm 2002. Jan;231(1):83-95 10.1016/S0378-5173(01)00871-7.
60. Hodges L A, Connolly S M, Band J, Mahony B O, Ugurlu T, Turkoglu M, Wilson C G and Stevens H N E: Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers. International journal of pharmaceutics 2009; 370:144-150.
61. Mooter VG, Kinget R. Oral colon-specific drug delivery: A review. Drug Delivery2: 1995;881-931
62. VyasSP, KharRK.Gastro retentive systems. In: VyasSP, Khar RK, editors. Controlled drug delivery: concepts and advances. New Delhi, VallabhPrakashan,2005;218-253.
63. Sangalli ME et al., In vitro and invivo evaluation of an oral system for time and /or site specific drug delivery, J Controlled release 73,2001,103-110.
64. Sinha VR, Kumria R. Microbially triggered drug delivery to the colon, EJPS,2003;18(1): 3-18.